Alnylam Focuses on Two Lead Programs, Won't Advance Others without Partners
January 12, 2012
Alnylam Focuses on Two Lead Programs, Won't Advance Others without Partners
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Unveiling New Strategy, Alnylam Aims to Debut Five Clinical Candidates by 2015
January 6, 2011 / Gene Silencing News - Alnylam Adds New Program to Pipeline as It Shelves Anemia Candidate
January 10, 2013 / Gene Silencing News - Alnylam Steps Back from Huntington's Drug Deal, Sees Two Partnerships by Year-End
May 10, 2012 / Gene Silencing News - Alnylam Provides Timelines for Drug Programs, Offers No Formal Guidance on Partnerships
February 16, 2012 / Gene Silencing News - Alnylam Presents Clinical Data from Cholesterol Drug Trial, Animal Data from Huntington's Program
January 5, 2012 / Gene Silencing News